Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma

Keyphrases

• Grafting from 100%
• Minimal Residual Disease 100%
• Stem Cell Grafts 100%
• Autologous Stem Cells 100%
• High-risk Neuroblastoma 100%
• Quantitative PCR 50%
• Unfavorable Outcome 50%
• Non-associated 50%
• CD34+ 50%
• Peripheral Blood Stem Cells 50%
• Harvest Time 50%
• Outcome Prediction 25%
• Clinical Significance 25%
• Large Cohort 25%
• Dutch 25%
• Specific Marker 25%
• Multivariate Analysis 25%
• Univariate Analysis 25%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 25%
• Neuroblastoma 25%
• RNA Markers 25%
• Stem Cell Collection 25%
• Retrospective Cohort 25%
• PHOX2B 25%
• 5-year OS 25%
• CHRNA3 25%
• Retrospective multicenter Study 25%
• Multivariate Cox Analysis 25%

Medicine and Dentistry

• Stem Cell 100%
• Ganglioneuroblastoma 100%
• Minimal Residual Disease 100%
• Real-Time Polymerase Chain Reaction 50%
• Peripheral Blood Stem Cell 50%
• Disease 25%
• Prospective Study 25%
• Clinical Significance 25%
• Multivariate Analysis 25%
• Proportional Hazards Model 25%
• Autologous Stem Cell Transplantation 25%
• Univariate Analysis 25%
• CHRNA3 25%
• Zalcitabine 25%

Immunology and Microbiology

• Stem Cell 100%
• Real-Time Polymerase Chain Reaction 50%
• CD34 50%
• Peripheral Blood Stem Cell 50%
• Autologous Stem Cell Transplantation 25%